Najnowsze artykuły: FDA grants breakthrough therapy tag to LLY's ovarian cancer candidateEli Lilly and Company LLY announced that the FDA has granted a Breakthrough Therapy designation to its novel folate receptor alpha (FRα) antibody-drug conjugate (ADC), sofetabart mipitecan (LY4170156) ...